Sign In

Renee Aguiar-Lucander

Chief Executive Officer, Director

Renee Aguiar-Lucander is the Chief Executive Officer of Calliditas Therapeutics AB, a position she has held since April 2017.1 She is an experienced executive with over 30 years in company management, strategic and financial development of US and European private and public companies, specializing in healthcare and technology sectors.2

Career Highlights

  • Led Calliditas from a small team of 10 to an international biopharmaceutical company with over 200 employees4
  • Oversaw the successful development and FDA approval of TARPEYO, the first approved therapy for IgA Nephropathy (IgAN)4
  • Previously served as Partner and COO of Omega Fund Management, an international venture capital firm focused on life sciences2
  • Worked as a Partner at 3i Group plc in London, managing publicly quoted assets and co-heading the global healthcare and technology portfolio2
  • Held the position of European Group Head and Managing Director at a global investment bank2

Education

  • BA in Accounting and Finance from Stockholm School of Economics (1982-1985)1
  • MBA from INSEAD (1991-1992)1

Expertise

Aguiar-Lucander brings a unique combination of financial acumen and life sciences experience to her role. Her background in investment banking and venture capital has been instrumental in navigating the capital-intensive nature of the biotech industry.4 She emphasizes the importance of balancing scientific innovation with strategic financial management to advance drug development programs.4

Under her leadership, Calliditas has achieved significant milestones, including the development of novel renal primary surrogate endpoints for clinical trials and securing the first-ever accelerated FDA approval for a nephrology drug.3

Highlights

Sep 25 · pharmexec.com
Finance to Pharma: Q&A with Renee Aguiar-Lucander
Aug 6 · biotech2050.com
From Banking to Biotech: Renée Aguiar-Lucander, CEO of Calliditas ...
From banking to biotech - Renée Aguiar-Lucander's unique path in ...

Related Questions

What are Renee Aguiar-Lucander's key achievements at Calliditas Therapeutics?
How did Renee Aguiar-Lucander transition from investment banking to biotech leadership?
What challenges did Renee Aguiar-Lucander face in developing treatments for rare diseases?
What strategic decisions did Renee Aguiar-Lucander make that contributed to Calliditas' success?
How has Renee Aguiar-Lucander's experience in corporate finance influenced her approach at Calliditas?
Renee Aguiar-Lucander
Renee Aguiar-Lucander, photo 1
Renee Aguiar-Lucander, photo 2
Add to my network

Location

Sweden